Papers
3
Total Citations
24
H-Index
3
About
Zongqin Zhang is a pioneering urologic surgeon and researcher at the forefront of robotic surgery, specializing in minimally invasive techniques for prostate and kidney cancer. His major contributions center on advancing single-port robotic systems, particularly through the clinical validation of novel platforms. In a landmark 2024 prospective study, Zhang demonstrated the safety and feasibility of the SHURUI Robotic Surgical System—a purpose-built single-port platform with deformable instruments—for retroperitoneal partial nephrectomy, a procedure that has since garnered 14 citations for its potential to reduce invasiveness. He has also critically evaluated surgical best practices; his 2023 meta-analysis on pelvic drain placement after robot-assisted radical prostatectomy (6 citations) challenged routine use, helping to streamline postoperative recovery. Earlier, Zhang developed the extraperitoneal tissue retraction technique to overcome workspace limitations in single-port radical prostatectomy using the da Vinci Si system (4 citations), showcasing his ingenuity in adapting existing multiport robots for single-port applications. With a growing citation impact, Zhang’s work is shaping the next generation of scarless, patient-friendly urologic oncology surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3